Neutrophil and macrophage immune effector pathways

Neutrophil and macrophage immune effector pathways encompass the diverse mechanisms by which innate immune cells detect, ingest, and destroy pathogens. Neutrophils primarily utilize phagocytosis, degranulation, and the formation of neutrophil extracellular traps (NETs) to provide rapid defense against invading microorganisms (Source: Rosales, C., 2018, Frontiers in Physiology). Macrophages complement this by acting as professional phagocytes and orchestrating the inflammatory response through the secretion of cytokines like TNF-alpha and IL-1 beta, as well as presenting antigens to the adaptive immune system (Source: Hirayama, D. et al., 2018, International Journal of Molecular Sciences). These pathways are critical for host survival, but their dysregulation is a hallmark of chronic inflammatory diseases, autoimmune disorders, and tissue damage in conditions like sepsis and acute respiratory distress syndrome. Pharmacological intervention typically targets specific nodes within these pathways, such as cytokine signaling or leukocyte trafficking, to mitigate tissue damage while attempting to preserve basic immune competence. Because this entry describes a broad set of biological processes rather than a single molecular entity, it is classified as a pathway rather than a specific therapeutic target.

Other names

Innate immune effector mechanismsMyeloid cell effector functionsNeutrophil and macrophage activation pathwaysPhagocyte effector pathways

Modulation of these pathways is typically achieved by inhibiting specific molecular components such as pro-inflammatory cytokines (e.g., TNF-alpha, IL-1 beta), blocking cell surface receptors, or inhibiting intracellular signaling kinases like Janus kinases (JAKs) to dampen the overall immune response.